StockWatch
·
Pharmaceuticals
Quarterly Result28 Jan 2026, 11:59 am

Sunil Healthcare Ltd to Approve Q3 Financial Results on Feb 06, 2026

AI Summary

Sunil Healthcare Ltd has announced that its Board of Directors will meet on February 06, 2026, to consider and approve the un-audited financial results for the quarter ended on December 31, 2025. The meeting will be held through video conferencing/audio visual connection as per SEBI regulations. The trading window will be closed from January 01, 2026, to February 08, 2026, under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Sunil Healthcare Ltd to consider and approve Q3 financial results on Feb 06, 2026
  • Meeting to be held through video conferencing as per SEBI regulations
  • Trading window to be closed from Jan 01, 2026, to Feb 08, 2026